Quoin Pharmaceuticals (QNRX) Stock News
$QNRX · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on Quoin Pharmaceuticals (QNRX) in the past 30 days. BORSA’s news read on QNRX is leaning bullish at 55/100, unchanged over 24 hours, based on 1 company event over the past 7 days. QNRX last closed at $4.15 on Oct 13, down 12.08% over five sessions and down 39.68% over the past month. Quoin Pharmaceuticals’ next earnings report is scheduled for Thursday, Nov 5.
The wire on $QNRX
newest first · updated · direct subject stories onlyBTIG Initiates Quoin Pharmaceuticals at Buy
BTIG started coverage of Quoin Pharmaceuticals with a Buy rating. No price target was given.
neutral 50 · impact 20